Home › High court won't hear appeal over $124M drug penalty
 

Keywords :   


High court won't hear appeal over $124M drug penalty

2016-01-11 16:27:59| Biotech - Topix.net

The Supreme Court won't hear an appeal from a Johnson & Johnson subsidiary assessed more than $124 million in penalties for deceptive marketing of an anti-psychotic drug. The justices on Monday let stand a lower court ruling that said Janssen Pharmaceuticals, Inc. should pay the penalties for violations of South Carolina law.

Tags: high court hear drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
11.05YouGov Unveils Americans Skincare Routines
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
11.05Indian Perfume Brand Eze Perfumes Enters US Market
11.05LOccitane Travel Retail Showcases Travel Retail Brand Portfolio at TFWA Asia Pacific
10.05How crops are being disaster-proofed
More »